Bo Hee Shin

1.3k total citations
7 papers, 505 citations indexed

About

Bo Hee Shin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Bo Hee Shin has authored 7 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Organic Chemistry. Recurrent topics in Bo Hee Shin's work include Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Quinazolinone synthesis and applications (3 papers). Bo Hee Shin is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Quinazolinone synthesis and applications (3 papers). Bo Hee Shin collaborates with scholars based in United States, South Korea and Germany. Bo Hee Shin's co-authors include Ciric To, Pasi A. Jänne, Michael J. Eck, Jaebong Jang, Nathanael S. Gray, Dries J.H. De Clercq, Mierzhati Mushajiang, Eunyoung Park, David E. Heppner and Thomas W. Gero and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Cancer Discovery.

In The Last Decade

Bo Hee Shin

7 papers receiving 496 citations

Peers

Bo Hee Shin
Stefanie Heynck Germany
Shruthi Vaidhyanathan United States
Mierzhati Mushajiang United States
Xiao-E Yan China
Edward J. Lewis United Kingdom
Leslie R. Pustilnik United States
Jodie Pang United States
L. Scarlett United Kingdom
Tony C. Luu United States
Stefanie Heynck Germany
Bo Hee Shin
Citations per year, relative to Bo Hee Shin Bo Hee Shin (= 1×) peers Stefanie Heynck

Countries citing papers authored by Bo Hee Shin

Since Specialization
Citations

This map shows the geographic impact of Bo Hee Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Hee Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Hee Shin more than expected).

Fields of papers citing papers by Bo Hee Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Hee Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Hee Shin. The network helps show where Bo Hee Shin may publish in the future.

Co-authorship network of co-authors of Bo Hee Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Hee Shin. A scholar is included among the top collaborators of Bo Hee Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Hee Shin. Bo Hee Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Gero, Thomas W., David E. Heppner, Tyler S. Beyett, et al.. (2022). Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC. Bioorganic & Medicinal Chemistry Letters. 68. 128718–128718. 13 indexed citations
2.
Heppner, David E., Ciric To, Marcel Günther, et al.. (2021). Design of a “Two-in-One” Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites. Journal of Medicinal Chemistry. 65(2). 1370–1383. 26 indexed citations
3.
Jang, Jaebong, Ciric To, Dries J.H. De Clercq, et al.. (2020). Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations. Angewandte Chemie. 132(34). 14589–14597. 13 indexed citations
4.
Jang, Jaebong, Ciric To, Dries J.H. De Clercq, et al.. (2020). Mutant‐Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug‐Resistant Mutations. Angewandte Chemie International Edition. 59(34). 14481–14489. 108 indexed citations
5.
To, Ciric, Jaebong Jang, Ting Chen, et al.. (2019). Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. Cancer Discovery. 9(7). 926–943. 250 indexed citations
6.
Clercq, Dries J.H. De, David E. Heppner, Ciric To, et al.. (2019). Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors. ACS Medicinal Chemistry Letters. 10(11). 1549–1553. 65 indexed citations
7.
Shin, Bo Hee, Seung‐Hyuk Choi, Eun Young Cho, et al.. (2004). Thiamine Attenuates Hypoxia-induced Cell Death in Cultured Neonatal Rat Cardiomyocytes. Molecules and Cells. 18(2). 133–140. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Heynck Breakdown of academic impact, for papers by Shruthi Vaidhyanathan Breakdown of academic impact, for papers by Mierzhati Mushajiang Breakdown of academic impact, for papers by Xiao-E Yan Breakdown of academic impact, for papers by Edward J. Lewis Breakdown of academic impact, for papers by Leslie R. Pustilnik Breakdown of academic impact, for papers by Jodie Pang Breakdown of academic impact, for papers by L. Scarlett Breakdown of academic impact, for papers by Tony C. Luu
Rankless by CCL
2026